New hope for Tough-to-Treat lung cancer patients
Disease control
Not yet recruiting
This study is testing an experimental drug called tarlatamab for people with an aggressive form of lung cancer that has worsened after their first round of chemotherapy and immunotherapy. It aims to see if the drug can help patients live longer and control the cancer. The trial w…
Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC